$AKRX Headlines Here are the best-performing stocks so

New Post Public Reply Private Reply Replies (0) Message Board

Jan 28, 2015 at 11:16 AM

$AKRX Headlines

Here are the best-performing stocks so far in 2015 11:47 a.m. Jan. 9, 2015 - Philip van Doorn
Time to play defense 1:53 p.m. Dec. 11, 2014 - The Trading Deck
6 stocks to watch 2:10 p.m. Oct. 22, 2014 - The Trading Deck
Follow through is the key for speculators 1:05 p.m. Oct. 21, 2014 - The Trading Deck
Volume a sign of the Nasdaq’s weakened state 1:11 p.m. Oct. 7, 2014 - The Trading Deck
Speculators live by the sword, die by the sword 2:13 p.m. July 8, 2014 - The Trading Deck
Dow, Nasdaq nail the breakout point 9:36 a.m. June 27, 2014 - Michael Ashbaugh
From tiny Akorns grow mighty oaks? 10:03 a.m. Nov. 21, 2013 - The Trading Deck
Rail-Splitter's top small-cap bets are worth watching 11:34 a.m. Nov. 4, 2013 - Insider Monkey
Akorn to buy Hi-Tech for $640 million in cash 7:02 a.m. Aug. 27, 2013 - MarketWatch.com
Monday’s biggest gaining and declining stocks 3:20 p.m. July 23, 2012 - MarketWatch
Corrective bounce, or sustainable upturn? 9:59 a.m. June 6, 2012 - Michael Ashbaugh
Charting a bearish double top 11:11 a.m. May 15, 2012 - Michael Ashbaugh
Charting a bearish double top 10:45 a.m. May 15, 2012 - Michael Ashbaugh
Wednesday’s biggest gaining and declining stocks 5:02 p.m. March 7, 2012 - Sue Chang
Tuesday’s biggest gaining and declining stocks 4:23 p.m. March 6, 2012 - MarketWatch
Stocks to watch Tuesday: Nutrisystem, Jakks 7:00 a.m. March 6, 2012 - MarketWatch
S&P 500 scratches out three-year high 11:07 a.m. March 2, 2012 - Michael Ashbaugh
Stocks to watch Friday: LinkedIn, LeapFrog, Nuance 6:46 a.m. Feb. 10, 2012 - MarketWatch
S&P 500 vies for positive 2011 finish 11:09 a.m. Dec. 23, 2011 - Michael Ashbaugh

Lannett Early Q2 Earnings Beat Estimates; Stock Jumps 11:20 a.m. Jan. 26, 2015 - Investors Business Daily
Will New FDA Approvals Boost Leading Drug Stock Akorn? 11:01 a.m. Jan. 22, 2015 - Investors Business Daily
4 Screaming Growth Stocks to Buy 4:36 a.m. Jan. 22, 2015 - InvestorPlace.com
Jefferies Weighs In On Specialty Pharmaceuticals After Management Meetings, Raises Price Targets On 5 Stocks 12:00 p.m. Jan. 20, 2015 - benzinga.com
FDA clears Akorn ophthalmic solution 7:15 a.m. Jan. 20, 2015 - Seeking Alpha
US Stock Futures Surge Ahead Of Earnings 6:16 a.m. Jan. 20, 2015 - benzinga.com
Akorn Receives FDA Approval for Phenylephrine HCl Ophthalmic Solution 6:01 a.m. Jan. 20, 2015 - benzinga.com
Will Akorn (AKRX) Continue to Surge Higher? - Tale of the Tape 7:32 a.m. Jan. 19, 2015 - Zacks.com
5 Pharmaceutical Stocks to Buy Now 1:30 a.m. Jan. 16, 2015 - InvestorPlace.com
3 Reasons To Be Bullish On Generic Drug Firm Akorn 1:12 p.m. Jan. 15, 2015 - Investors Business Daily
Insider Trading Alert - BKD, AGX And AKRX Traded By Insiders 10:06 a.m. Jan. 13, 2015 - TheStreet.com
Akorn Sees Strong Pricing In Generic Drugs 4:51 p.m. Jan. 12, 2015 - Investors Business Daily
Biggest Upside Of Current Best Market-Maker Forecasts 9:43 p.m. Jan. 11, 2015 - Seeking Alpha
Week In Review: WuXi PharmaTech Pays $65 Million For Genomics Company 11:10 a.m. Jan. 11, 2015 - Seeking Alpha
Four Best Gains In IBD 50: Nothing To Do With Oil 5:35 p.m. Jan. 9, 2015 - Investors Business Daily
Weekly Review Shows Five Industries Gain In December 5:06 p.m. Jan. 8, 2015 - Investors Business Daily
Top 4 NASDAQ Stocks In The Drugs Generic Industry With The Highest EPS Growth Forecast For Next 5 Years 3:33 a.m. Dec. 29, 2014 - benzinga.com
Actavis' Alzheimer's Drug Approved; Bystolic Gets CRL - Analyst Blog 1:20 p.m. Dec. 26, 2014 - Zacks.com
Adamas Pharmaceuticals (ADMS) Jumps: Stock Gains 9.9% - Tale of the Tape 9:25 a.m. Dec. 26, 2014 - Zacks.com
Strength Seen in Parnell (PARN): Stock Moves 5.3% Higher - Tale of the Tape 9:25 a.m. Dec. 24, 2014 - Zacks.com

Akorn Set to Join the S&P MidCap 400; United Insurance Holdings, ANI Pharmaceuticals to Join the S&P SmallCap 600 5:46 p.m. Jan. 27, 2015 - PR Newswire - PRF
Pre-Market Pulse on Pharma Stocks - Teva Pharma Industries, Allergan, Endo Intl., Akorn, and Depomed 8:30 a.m. Jan. 16, 2015 - PR Newswire - PRF
Akorn Confirms Generic Durezol(R) Patent Challenge 5:30 p.m. Jan. 15, 2015 - GlobeNewswire
Akorn to Present at the 33rd Annual J.P. Morgan Healthcare Conference 9:30 a.m. Dec. 19, 2014 - GlobeNewswire
Technical Data on Pharma Stocks - Pfizer, Merck, AbbVie, Akorn, and The Medicines 9:10 a.m. Dec. 12, 2014 - PR Newswire - PRF
Akorn Reports Preliminary 2014 Third Quarter Results 7:31 a.m. Nov. 6, 2014 - GlobeNewswire
Technical Coverage of Pharma Stocks - Repros Therapeutics, Nektar Therapeutics, Akorn, AcelRx Pharma, and Pernix Therapeutics Holdings 8:45 a.m. Nov. 3, 2014 - PR Newswire - PRF
Akorn, Inc. Announces Third Quarter 2014 Earnings Release and Conference Call Information 10:04 a.m. Oct. 21, 2014 - GlobeNewswire
Sunovion Pharmaceuticals Inc. to Divest Xopenex® (levalbuterol HCI) Inhalation Solution (IS) to Akorn, Inc. 3:22 p.m. Sept. 30, 2014 - BusinessWire - BZX
Akorn Acquires Xopenex(R) (levalbuterol HCI) Inhalation Solution From Sunovion 3:16 p.m. Sept. 30, 2014 - GlobeNewswire
Technical Snapshot on Pharma Stocks - Allergan, Akorn, Mallinckrodt, Mylan, and AVANIR Pharma 8:25 a.m. Sept. 8, 2014 - PR Newswire - PRF
Restaurant Openings, Financial Releases, Completed Projects, Regulatory Updates, and Strategic Acquisitions - Research Reports on El Pollo Loco, SunEdison, Workday, PCG and Akorn 7:30 a.m. Sept. 5, 2014 - PR Newswire - PRF
Akorn Completes Acquisition of VersaPharm 7:51 a.m. Aug. 12, 2014 - GlobeNewswire
Market Updates on Pharma Stocks -- Theravance, Akorn, Endo Intl., Pernix Therapeutics, and Depomed 8:20 a.m. Aug. 7, 2014 - PR Newswire - PRF
Akorn Reports Preliminary 2014 Second Quarter Results 5:05 a.m. Aug. 5, 2014 - GlobeNewswire
Global Parkinson%s Disease Market 2014-2018 5:42 p.m. July 28, 2014 - PR Newswire - PRF
Akorn, Inc. Announces Second Quarter 2014 Earnings Release and Conference Call Information 10:34 a.m. July 15, 2014 - GlobeNewswire
Early Briefing on Pharma Stocks -- Research on Novartis, Akorn, Horizon Pharma, and Mallinckrodt 5:50 a.m. July 2, 2014 - PR Newswire - PRF
Divestitures, Agreement for Developmental Rights, Data Presentations, Technical Update, and Licensing Agreements - Analyst Notes on Akorn, Merrimack, Avanir, Omeros and TG Therapeutics 5:40 a.m. June 27, 2014 - PR Newswire - PRF
Akorn Divests ECR Pharmaceuticals to Valeant 10:11 a.m. June 20, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bank Leumi Q3 Earnings Preview: Key Dates & Insights

A Closer Look at Bank Leumi's Upcoming Q3 Release Take a seat, folks. Bank Leumi’s gearing up to spill the beans on their Third Quarter 2026 earnings come November 17th. If you’re in the financial world, you might want to mark your calendar because these reports tend to shake things up. You know how these go - numbers rolling out, market responses, and plenty of...

Domino’s Faces Legal Heat: Investors' Eyes On DPZ

Domino's Pizza Under the Legal Microscope Picture this, folks: Domino's Pizza (NASDAQ: DPZ) is caught in a legal whirlwind that might give its shareholders a rollercoaster of a read in the coming weeks. On the docket is a serious probe led by Johnson Fistel, a law outfit with quite the reputation for defending shareholder interests. The focus? Whether certain hot shots at...

xTool X1: Redefining Laser Fabrication for Makers

The Next Generation of Laser Fabrication Whenever a new gizmo hits the market, it's usually just an upgrade in disguise—faster, shinier, a touch more wattage. Not this time. xTool shook things up by rolling out the X1, a laser platform that gets what small businesses and makers truly crave: versatility and long-lasting potential. This bad boy does more than engrave; it...

BD's New Liverty™ TIPS Stent: A Game Changer?

Could This Be the Breakthrough for Portal Hypertension? Now, here's something that might just turn a few heads in the medical world. BD has launched their Liverty™ TIPS Stent Graft in the U.S., a move set to shake up the landscape for treating portal hypertension. This isn't just another shiny new gadget—it's a promise of more personalized patient care in a field...

BASIS Bellevue Expands with New K-4 Campus

A New Era for Young Learners in Bellevue When a community-driven school like BASIS Independent Bellevue makes a move to expand, it doesn't happen in a vacuum. They're not just building another campus—they're aiming to sculpt the future right here in Bellevue, and boy, do they have a plan. The new Lower School campus opening come Fall 2027 is dedicated to kiddos in...

EzAccounting: Your Q3 IRS Filing Gets a No-Nonsense Tool

Taking Tax Deadlines Head-On Tax season's got businesses sweating all over the country, but it doesn't have to be a full-scale panic attack if you've got the right gear. That's where ezAccounting steps in, dishing out a reliable solution to hit those looming IRS Form 941 deadlines without a migraine. By November 2, 2026, companies are looking to dodge the bullet of...

Amgen Q3 2026 Results: What Investors Should Know

Amgen Prepares to Reveal Third Quarter 2026 Financials If there's one thing I've learned about investing, it's that the devil's in the details, and Amgen's (NASDAQ:AMGN) upcoming webcast for its third quarter 2026 financial results is exactly the kind of detail that sets market-watchers' hearts racing. Scheduled for November 3, just after the U.S. markets close, this is...

California Cash Surplus Raises Investor Eyebrows

California's Unexpected Financial Bounty Kicking things off with a real humdinger: California's September cash flow exceeded expectations by a whopping $2.9 billion. That's not chump change, folks. It's like finding an extra twenty in your coat pocket but on a much grander scale. Impressively, the state's General Fund receipts tallied up to $22.9 billion, surpassing the...

York Space Systems Faces Turbulence Amid Investor Lawsuit

York's Shaky Strategy Under the Microscope How do you go from sky-high ambitions to a grinding halt in a matter of weeks? This ain’t your typical Wall Street plot twist—it involves York Space Systems, or NYSE:YSS. These guys promised dominance in the Space Development Agency’s Transport Layer program, only to have their shooting star come crashing down. And now,...

Review Insurance Coverage After Major Life Changes

Why Life Changes Demand an Insurance Review The nitty-gritty of life doesn't sit still—marriages, babies, job changes, and home deals or steals each bring their own clutter to the table. One thing's for sure: when your life shifts, your insurance ought to keep pace. Insurance Agent Nick Hogan drops the dime in the latest HelloNation article, laying it bare why...